What are the causes of urticaria in a patient with positive anti‑thyroid peroxidase antibodies, positive antinuclear antibodies (ANA), and normal IgE levels?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Causes of Urticaria

In a patient with positive anti-thyroid peroxidase antibodies, positive ANA, and normal IgE levels, the urticaria is most likely autoimmune in nature—specifically type IIb autoimmune chronic spontaneous urticaria (CSU), characterized by IgG autoantibodies against IgE or its high-affinity receptor (FcεRI) on mast cells. 1, 2

Understanding the Autoimmune Profile

Your patient's laboratory findings are highly suggestive of autoimmune CSU:

  • Positive anti-TPO antibodies: Thyroid autoimmunity occurs in 14% of chronic urticaria patients versus 6% in controls 1. This association is well-established but the thyroid antibodies themselves are not directly pathogenic for urticaria—they represent parallel autoimmune phenomena 3.

  • Positive ANA: This significantly correlates with more severe, refractory disease. Patients with positive ANA have an odds ratio of 2.3 for being refractory to antihistamines 4. Recent data shows 61.6% of CSU patients may be ANA-positive, with nuclear fine-speckled and nucleolar patterns being most common 5.

  • Normal IgE levels: This is a critical finding. Patients with autoimmune CSU (type IIb) typically have low or very low total IgE levels, while elevated IgG-anti-TPO is common 2. A high ratio of IgG-anti-TPO to total IgE is currently the best surrogate marker for autoimmune CSU 2. Your patient's normal IgE makes type I autoallergic CSU (mediated by IgE autoantibodies) less likely.

Broader Etiologic Categories

The British Association of Dermatologists guidelines [1-1] classify urticaria causes as:

Immunological Mechanisms

  • IgE-mediated (Type I autoallergic CSU): IgE autoantibodies to self-antigens 2
  • IgG-mediated (Type IIb autoimmune CSU): IgG or IgM autoantibodies against IgE or FcεRI—found in 10-40% of chronic urticaria patients 3, 6
  • Allergic reactions: Environmental allergens (latex, nuts, fish) confirmed by skin-prick testing or specific IgE 1

Non-immunological Mechanisms

  • Direct mast cell degranulation: Codeine, radiocontrast media 1
  • Leukotriene-mediated: Aspirin, NSAIDs, dietary pseudoallergens (salicylates, azo dyes, food preservatives) 1
  • Bradykinin-mediated: ACE inhibitors causing angioedema 1

Associated Conditions

  • Helicobacter pylori: Meta-analysis shows urticaria resolution more likely when H. pylori eradication is successful (Quality of evidence I) 1. Reported in 47-75% of chronic urticaria patients 6.
  • Coeliac disease: Significantly higher prevalence in children/adolescents with severe chronic urticaria 1
  • Occult infections: Dental abscess, gastrointestinal candidiasis—little supporting evidence (Quality of evidence III) 1

Physical Urticarias

Mechanical (dermographism, pressure, vibration), thermal (cholinergic, cold, heat), or other triggers (aquagenic, solar, exercise-induced) 1

Clinical Implications for Your Patient

This patient likely has type IIb autoimmune CSU with concurrent thyroid autoimmunity. Consider:

  1. Autologous serum skin test (ASST): Offers reasonably sensitive/specific screening for histamine-releasing IgG autoantibodies 1. ASST-positive patients have significantly higher disease activity (mean UAS7 score 23.96 vs 13.51, p=0.001) 7.

  2. CU Index testing: If available and patient is antihistamine-refractory, this has the strongest correlation with disease severity (odds ratio 4.5) 4.

  3. Thyroid function tests: Screen for underlying thyroid dysfunction requiring treatment 1, 8.

  4. Treatment expectations: Anti-TPO negative patients respond better to omalizumab 9. Your patient's positive anti-TPO may predict poorer omalizumab response, though combined with IgE levels this can support clinical decision-making 9.

Common Pitfalls

  • Don't assume thyroid antibodies cause urticaria directly—they're associated parallel autoimmune events 3
  • Don't routinely screen for malignancy—no statistical association exists (Quality of evidence II-ii) 1
  • Avoid extensive testing in mild disease responding to antihistamines—investigations should be guided by history and reserved for nonresponders 1

References

Guideline

chronic spontaneous urticaria guidelines: what is new?

Journal of Allergy and Clinical Immunology, 2022

Research

The role of autoimmune testing in chronic idiopathic urticaria.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2012

Research

Thyroid autoimmunity in chronic urticaria.

Allergy and asthma proceedings, 2001

Research

A Meta-Analysis of Anti-Thyroid Peroxidase Antibody and Omalizumab Response in Chronic Spontaneous Urticaria.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.